Markets
60 Degrees Pharmaceuticals CEO Buys $10,131 in Stock: What Insider Conviction Signals for SXTP
The CEO of 60 Degrees Pharmaceuticals has made a direct, open-market purchase of SXTP shares worth $10,131 — a move that insider-signal watchers say carries outsized weight for a micro-cap biotech. Here is what the trade means and what to watch next.